Healthtech Startups
16,920 companies tagged Healthtech, with their investors and founders.
Inhalon Biopharma is a clinical-stage biotechnology company developing inhaled "muco-trapping" antibody treatments for acute respiratory infections, including RSV, influenza, human metapneumovirus, and SARS-CoV-2. Its therapies aim to treat active infection directly in the lung.
2 investors
Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.
2 investors
ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases. The company leverages its management team's extensive experience in drug development and commercialization across all stages.
2 investors
Innerspace is a health-tech company that helps pharmaceutical companies improve quality, efficiency, and compliance in aseptic manufacturing. Its Frame-by-Frame methodology captures industry knowledge to power data-driven digital solutions for process optimization, risk assessment, and training, including virtual reality-based cleanroom training.
2 investors
Innerwell is a telehealth mental health platform offering virtual psychiatry and therapy along with treatments like ketamine therapy, EMDR, and psychedelic integration. It coordinates care through a network of psychiatrists, therapists, and care advocates for patients seeking treatment for conditions such as depression and anxiety.
2 investors
InnovAge operates a Program of All-Inclusive Care for the Elderly (PACE), providing integrated healthcare and social services to seniors. The organization delivers coordinated care designed to help elderly individuals remain independent and in their communities.
2 investors
InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease. The company is a medical device maker focused on structural heart interventions for cardiac patients.
2 investors
Inocras is a bioinformatics company that uses whole genome sequencing and proprietary analytics to produce clinically actionable insights for patient diagnosis and treatment, operating a CLIA-certified and CAP-accredited lab. It serves patients, clinicians, and researchers with whole genome diagnostic testing, sequencing and interpretation services, genetic counseling, and clinical trial matching.
2 investors
2 investors
InsideTracker provides personalized health insights by analyzing biological markers and genetic data to deliver customized recommendations for nutrition, fitness, and lifestyle optimization for individuals seeking longevity and preventive wellness.
2 investors
Instalabel develops AI tools for radiology and patient care that make artificial intelligence observable and controllable for radiologists. The company builds medical AI solutions focused on healthcare applications.
2 investors
InstantScripts is an Australian telehealth platform that connects patients with registered doctors for online consultations, prescription delivery, and health services available 24/7 across Australia. The service is wholly owned by Wesfarmers Health and covers a range of treatment areas including contraception, mental health, chronic conditions, and general medical care.
2 investors
Instapath develops rapid digital pathology microscopy platforms that enable cancer diagnosis from tissue samples in minutes rather than days. The technology serves pathology labs and healthcare providers to accelerate cancer diagnosis and reduce repeat biopsy procedures.
2 investors
InStockRx operates a pharmacy-to-pharmacy marketplace platform enabling independent pharmacies to buy and sell surplus medications while maintaining DSCSA compliance. The platform helps pharmacies reduce waste, save on medication costs (averaging $400K annually vs NADAC pricing), and build trusted trading networks.
2 investors
Insulet develops the Omnipod, a tubeless, wearable, disposable insulin delivery Pod, along with automated insulin delivery systems for people managing insulin-dependent diabetes. Its products serve people with diabetes and their caregivers in the medical device and diabetes management category.
2 investors
Intact Therapeutics develops next-generation biopharmaceutical therapies for gastrointestinal diseases to address unmet clinical needs. The company is clinical-stage and focused on improving patient outcomes through innovative medicines.
2 investors
Integrate Health works alongside governments and local communities in West Africa to strengthen primary healthcare delivery through an integrated, data-driven approach. The organization aims to achieve Universal Health Coverage across West Africa, with a focus on women-led service design and community ownership.
2 investors
Intelligent Locations builds INTRAX, a cloud-based real-time location system (RTLS) that tracks assets, patients, staff, and environmental conditions in hospitals, with AI-powered analytics and reporting. It serves healthcare enterprises to optimize clinical and non-clinical operations such as asset utilization, patient throughput, staff support, and compliance monitoring.
2 investors
Intelligent Observation provides a subscription-based hand hygiene compliance monitoring system for hospitals, using near-field magnetic induction (NFMI) smart badges and a cloud dashboard to replace manual visual observation. The system aims to reduce healthcare-acquired infections and create safer environments for patients and staff.
2 investors
Interobio Systems develops stem-cell-derived human intestinal organoids that include functioning neurons, blood vessels, muscle, and intestinal lining for use in preclinical drug testing. The company applies human biology and organoid technology to support drug discovery and development.
2 investors
Teladoc Health provides virtual care services connecting patients with providers for medical care, mental health, and chronic condition management. It serves health plans, employers, and hospitals in the U.S. with connected care technology and benefits solutions.
2 investors
Intrommune is a biotechnology company developing oral mucosal immunotherapy (OMIT), which delivers allergenic proteins through a specially formulated toothpaste to treat peanut and other food allergies. Its products target patients and families managing food allergies, spanning early allergen introduction in at-risk children and treatment options for those living with food allergy.
2 investors
Intuitive Care provides automation software that connects healthcare providers' systems to health insurer portals to run the financial revenue cycle, handling digital authorization, billing, reconciliation, and claim denial (glosa) appeals. It targets large hospitals, networks, and diagnostic groups in Brazil operating at high volume and complexity.
2 investors
2 investors